30 September 2022
Allied Minds plc
("Allied Minds", the "Group", or the "Company")
Half-Yearly Report for the six months ended 30 June 2022
Allied Minds plc (LSE: ALM), the IP commercialisation company focused on early-stage company development within the technology sector, announces its unaudited interim results for the six months ended 30 June 2022.
Investment and Financial Highlights
·
· Cash and cash equivalents at 30 June 2022:
Selected Portfolio Company Highlights
· BridgeComm ("BCI") (consolidated subsidiary at 30 June 2022, equity accounted investment after post period end transaction):
o Post period end, closed a
o Revised structure, post period end, reduced Allied Minds' fully-diluted ownership to 39.77% that sets up BCI to potentially deliver substantial upside return.
o BCI's focus is now on commercialising its technology - which will require approximately
o BCI is in the later stages of bidding on two contracts, either of which could provide further funding of up to
o Allied Minds and Aeroequity Industrial Partners ("AEI") have each committed an additional
· Federated Wireless ("Federated") (equity accounted investment):
o Federated closed a
o Allied Minds' bridge financing fully converted following the completion of the Series D funding rounds. As a result, Allied Minds' fully‐diluted ownership of the issued share capital of Federated Wireless stands at 23.96%.
o Federated delivered H1 revenue growth in line and EBITDA and cash generation ahead of expectations.
o Federated Wireless deployed its private wireless and shared spectrum technology to deliver industry-first solutions across new applications:
§ Collaborated with Blue White Robotics and Intel to build an autonomous agriculture solution connected over a private wireless network.
§ Partnered with CalChip Connect to deliver end-to-end solutions and services to power plug-and-play decentralized 5G networks.
o Post period Federated entered into a partnership agreement with US Real Estate owner, JBG SMITH, demonstrating further ongoing progress.
· OcuTerra (ordinary and preference share holding investment held at fair value):
o Post period, OcuTerra commenced the Phase 2 trial of its non-invasive eyedrops (OTT166), an important milestone in its efforts to develop the first, topical eye drop treatment for diabetic retinopathy.
o OcuTerra continued to strengthen its managerial and clinical team with the appointment of eye care industry veteran, Majid Andersi, MD, as Vice President of Clinical and Medical Affairs.
· Orbital Sidekick ("OSK") (preference share holding investment held at fair value):
o Signed a contract with one of the largest pipeline operators in
o Entered an agreement with In-Q-Tel to deliver timely and relevant insights to IQT's government partners.
o Strong interest from a number of clients wishing to participate in its alpha/beta launch of six satellites in 2023.
o Orbital Sidekick continues to have investor support and a bank facility to allow it to continue operating until June 2023 with the potential for additional follow-on funding.
· Touch Bistro (ordinary share holding investment held at fair value)
o On 28 March 2022, Allied Minds announced that it had completed the disposal of its residual shareholding in Touch Bistro for
o On 23 August 2022, the remainder of the shares held in escrow were released, resulting in cash received of
Corporate Developments
· Reshaped the board following the departure of Harry Rein (Non-Executive Chairman) and Mark Lerdal (Non-Executive Director); Bruce Failing appointed Non-executive Chairman while Sam Dobbyn and Casey McDonald joined as Non-Executive Directors.
· Following a formal review of the Company's strategic options, the Board has considered that a public listing is no longer in the best interests of the Company due to the prohibitively high costs relative to Allied Minds' current size. The Board is now formally consulting with shareholders regarding a possible delisting of the Company.
Bruce Failing, Chairman of Allied Minds, commented:
"Our core focus is to maximize returns for our shareholders by supporting our portfolio companies while maintaining disciplined cost control. Following a formal strategic review of the business, the Board has concluded that the costs of maintaining a public listing are prohibitively high for a company of Allied Minds' current size and we are now consulting with shareholders ahead of a proposed delisting.
"The board remains positive about the prospects of our portfolio companies and their ability to meet their planned technical and commercial goals. We continue to see financing secured (albeit additional financing rounds will be required for BridgeComm and Orbital Sidekick), new contracts signed and partnerships agreed with industry leaders. Our portfolio continues to hold substantial value, which we believe can be realized and returned to shareholders within a timeframe of 18-24 months."
For further information, please contact:
|
Allied Minds plc Bruce Failing
|
c/o Instinctif Partners |
|
|
|
|
Instinctif Partners (Communications) |
|
|
Tim Linacre / Rozi Morris / Joe Quinlan |
alliedminds@instinctif.com |
About Allied Minds
Allied Minds plc is an IP commercialisation company focused on early stage company development within the technology sector. With origination relationships that span US federal laboratories, universities, and leading US corporations, Allied Minds historically created, and now operates and funds, a portfolio of companies to generate long-term value for its investors and stakeholders. Based in
Forward looking statements
This 2022 half-yearly report may contain statements that are or may be forward-looking statements, including statements that relate to the Company's future prospects, developments and strategies. The Group considers any statements that are not historical facts as "forward-looking statements". The forward-looking statements are based on current expectations and are subject to known and unknown risks and uncertainties that could cause actual results, performance and achievements to differ materially from current expectations, including, but not limited to, those risks and uncertainties described in the risk management section of the 2021 Annual Report. These forward-looking statements are made in good faith based on assumptions regarding the present and future business strategies of the Company and the environment in which it will operate in the future and such statements should be treated with caution due to the inherent uncertainties, including both economic and business risk factors, underlying any such forward-looking information. Each forward-looking statement speaks only as at the date of this half-yearly report release. Except as required by law, regulatory requirement, the Listing Rules and the Disclosure Guidance and Transparency Rules, neither the Company nor any other party intends to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise.
INTERIM MANAGEMENT REPORT
Overview
Allied Minds is an IP commercialisation company primarily focused on early-stage company development within the technology sector.
We have historically invested in companies at an early stage, including seed investments to build companies based on a technical breakthrough or invention. As such, our investments have significant upside potential, but also carry significant risk inherent in the early-stage model.
There are currently five portfolio investments based upon a broad range of underlying innovative technologies ranging from wireless connectivity to space-based imagery and analytics.
The Group remains focused to execute its plan to maximise the value of its portfolio company interests and deliver well-timed, risk-adjusted returns for its shareholders.
Model
As a manager of a technology-focused portfolio in which we hold significant ownership positions, we seek to provide hands-on support over the life of our companies to support their growth, focusing on enabling and driving commercialisation, supporting follow-on investment rounds, and positioning for superior monetisation opportunities.
We seek to play an active role in developing the strategic direction of our portfolio companies and driving ongoing planning and assessment. Our Non-Executive Directors serve on the boards of directors of our portfolio companies, working with them to develop and implement strategic, operating and funding plans. Following the recent changes to the board of Allied Minds, Bruce Failing currently sits on the board of Federated Wireless, BridgeComm and Orbital Sidekick. In addition, Sam Dobbyn has now been appointed director of Federated Wireless alongside Mr. Failing, while Casey McDonald is due to be appointed to the board of BridgeComm and Sam Dobbyn is due to be appointed to the board of Orbital Sidekick.
We evaluate on an on-going basis the progress and potential of each of the portfolio company's businesses and make strategic and funding decisions based on the regular review of operational and financial performance and the achievement of key milestones. Together with our management, the respective portfolio company boards of directors define the critical milestones, or inflection points, for each portfolio company and measure tangible progress towards commercialisation and the key factors for a successful monetisation event.
Where appropriate, we seek to include partners who validate the market opportunity and can provide support and/or commercial commitments to accelerate, expand and/or de-risk the path to commercialisation. Co-investors in later rounds include financial, strategic and commercial partners.
Strategy
Allied Minds is focused on supporting its existing portfolio companies and maximising monetisation opportunities for portfolio company interests. In March 2022, the Company announced that it was undertaking a formal strategic review, aimed at creating and / or realising shareholder value. As part of this strategic review, the Board has sought to ensure that the Company is being managed in as cost-efficient manner as possible. In conducting this review, the Board considers that the costs of maintaining a premium listing on the Official List and the Main Market of the London Stock Exchange prohibitively high relative to Allied Minds' current size and deem maintaining a public listing is no longer in the best interests of the Company and its Shareholders as a whole.
The Allied Minds Board is now formally consulting with shareholders regarding a possible delisting of the Company. Should the Board decide to proceed with a delisting, the Company will publish a shareholder circular detailing the rationale for the decision and giving notice of a General Meeting at which shareholders will vote on a resolution to delist and will set out the expected timetable for the delisting to become effective if the resolution to delist is passed.
Outlook
There was good technical and commercial progress from certain portfolio companies during the first half of 2022, including a successful funding round at Federated Wireless at an improved valuation. The milestones achieved demonstrate the innovative nature of the products and services within the portfolio, which address a range of large potential markets and provide a strong platform for creating shareholder value.
The Board of Allied Minds continually assesses its portfolio of investments and takes informed decisions supported by up-to-date information. As part of this process, a member of the Allied Minds board sits on the boards of all our material investments, and this remains the case following the recent departure and appointment of certain directors at Allied Minds.
Although Allied Minds' portfolio companies are mostly at a relatively early stage in their lifecycle, the Board remains positive about their prospects upon exit if the portfolio companies continue to meet their planned technical and commercial goals.
Management continuously monitors and reviews international risks such as economic headwinds, including inflationary pressures, interest rates and component price increases, as well as changes in political and regulatory requirements. The Directors have also put in measures to mitigate against the risks to the business such as the continued impact of COVID-19. The situation in
Portfolio Company Valuation
Of the Company's five active portfolio companies, the Company holds a significant minority stake in three of these companies and a small position in both OcuTerra and Concirrus. In each case, where Allied Minds holds a significant minority stake, it is able to exercise its influence over the portfolio company by virtue of its large, albeit minority, ownership stake in the portfolio company and its representation on the board of directors. The investment in preferred stock in these portfolio companies is accounted for under IFRS 9 and is classified by the Company as an investment at fair value in the Company's consolidated financial statements. Due to the equity-like characteristics of the Company's common stockholdings in Federated Wireless, this investment is accounted for under IAS 28 and is classified by the Company as investments in associates. Accordingly, since Allied Minds has significant influence over this entity through the voting rights held, it gives access to the returns associated with an ownership interest in this associate. For Ordinary stock holdings, where the group does not have significant influence, these investments are held at fair value in the Company's consolidated financial statements.
Allied Minds provides qualitative and quantitative disclosure in relation to the commercial and financial progress of its portfolio companies, and directional commentary on valuation. In addition, where commercially possible, Allied Minds provides, for each portfolio company: (i) the date of the last equity funding round, (ii) the post-money valuation of such round, (iii) the named key co-investors in such round, and (iv) the Company's issued and outstanding ownership (when provided by the portfolio company), and fully-diluted ownership, of such portfolio company.
This information is set forth in the Portfolio Review and Developments section below. The ownership interests are as of 9 September 2022. The fully-diluted percentages take into account outstanding stock options granted to employees, directors and advisors, current stock options available for grant pursuant to the company's stock option plan, and outstanding warrants to purchase common and preferred stock.
The post-money valuations disclosed for each entity below do not represent IFRS 13 fair values but rather, are based on the pre-money valuation set by the investors in the latest financing round plus the total money raised in that round.
There can be no guarantee that the aforementioned post-money valuations of the portfolio companies will be considered to be correct in light of the future performance of the various companies, or that the Company would be able to realise proceeds in the amount of such valuations, or at all, in the event of a sale by it of any of its portfolio companies or its ownership interest in such portfolio companies.
Portfolio Review and Developments
----------
1) BridgeComm Inc. (BCI) (consolidated subsidiary at 30 June 2022, equity accounted investment after post period end transaction)
BCI is developing high-speed optical wireless communications to provide fast, secure, enterprise-grade broadband service for space, terrestrial and 5G connectivity. It has created in the lab, and demonstrated over 100 meters, high-capacity, secure, one-to-many optical communications capabilities that may represent a paradigm shift in the low earth orbiting satellite constellations communications and battlefield communications. This technology offers a potential low-cost alternative to laying fibre optic cable in underserved and hard to reach cellular geographies.
As previously announced, in order to ensure BCI can bid for US Space Development Agency business as a prime contractor, BCI could not be majority owned by a foreign company. Allied Minds therefore agreed to a new ownership structure with Aeroequity Industrial Partners ("AEI"). Post the period end, in order to implement this structure,
Further, post period end, BCI closed a
In addition to the restructuring enabling BCI to qualify as a US company, BCI will also benefit from the significant US government contacts and aerospace knowledge that AEI brings to the company. Also, Boeing, a significant BCI customer is an investor through Space X in AEI. Allied Minds believes that taking an economic write-down now sets the company up for future success and the potential for a significant total return.
BridgeComm now needs to commercialise its technology, which is expected to cost approximately
While the process of going from the lab to a commercialised product is uncertain, the economic upside for BCI and Allied Minds could be substantial and as such we are optimistic for BCI's success.
Holdings and valuation:
· Date of Last Funding Round: September 2022
· Post-Money Valuation:
· Co-Investors: AE Industrial HorizonX Venture Fund I, LP
· Allied Minds' Issued and Outstanding Ownership: 41.49%
· Allied Minds' Fully-Diluted Ownership: 39.77%
2) Federated Wireless Inc. (Federated) (equity accounted investment)
Founded in 2012, Federated is the market leader in Citizen Band Radio Service (CBRS) shared spectrum. Shared spectrum, also known as CBRS, is an innovative technology that delivers the best attributes of traditional wireless and Wi-Fi, with lower fixed cost, higher quality, and greater efficiency and scale.
As the first to market with a Spectrum Access System ("SAS"), Federated Wireless is the nationwide leader in
Federated delivered an encouraging first half performance with revenue growth in all segments. This led to revenues for the period in line with the plan which underpinned the most recent fundraise and valuation. Quarter on quarter growth was particularly noteworthy with the second quarter being up 30% on the first. The business delivered a gross margin on track for the year in first half that was 7% ahead of plan, resulting in EBITDA and cash coming out well ahead of expectations.
Federated Wireless entered a joint industry collaboration with Blue White Robotics and Intel to automate agricultural solutions. This first-of-a-kind implementation greatly reduces the barriers for growers to adopt automation that can improve business outcomes while addressing labour shortages. Partnering with a
Federated Wireless also partnered with leading IoT distributor CalChip Connect to deliver end-to-end solutions and services to power plug-and-play decentralized 5G networks. The strategic collaboration provides an end-to-end service for consumers and small enterprises to rapidly implement a plug-and-play decentralized 5G network solution that can be setup in as little as 20 minutes.
In H1 2022, Federated Wireless raised
The Board of Federated expects continued growth over the second half of the year. These expectations come with the usual risks commensurate with high growth businesses of this nature.
Post period end, Federated entered into an Innovative Private Wireless Partnership with JBG SMITH. JBG SMITH is an owner, operator and investor in dynamic mixed-use Real Estate portfolios in and around
Holdings and valuation:
· Date of Last Funding Round: May 2022
· Post-Money Valuation:
· Co-Investors: Cerberus Capital Management LLP and GIC (
· Allied Minds' Issued and Outstanding Ownership: 27.04%
· Allied Minds' Fully-Diluted Ownership: 23.96%
3) OcuTerra Therapeutics, Inc. (ordinary and preference share holding)
OcuTerra is a clinical stage ophthalmology company developing innovative small molecule drugs for non-invasive use in treating ophthalmologic diseases that are currently treated in the early stages with a "watch and wait" protocol.
Following the completion of a
Post period, in August 2022, OcuTerra announced the first patient had been dosed in its Phase 2 DR:EAM (Diabetic Retinopathy: Early Active Management) clinical trial. OTT166 is a novel small molecule selective integrin inhibitor that is designed with purpose engineering to have the required physiochemical characteristics to be able to reach the retina from eye drop application.
OTT166 has been specifically designed to be administered as an eye drop by the patient at home before diabetic retinopathy has advanced to a vision-threatening complication, such as diabetic macular edema. By potentially enabling earlier non-invasive treatment, OcuTerra's goal is to prevent progression, thereby delaying or completely eliminating the need for intravitreal injections and/or destructive laser procedures.
Phase 1b clinical trials of OTT166 eye drops in patients with diabetic retinopathy and wet AMD previously demonstrated safety, tolerability and clear clinical evidence of biological activity. If the Phase 2 trial is successful, the next step would be a Phase 3 trial involving more patients and if successful in meeting the clinical end points application to the FDA for approval.
In line with the company's previously stated strategy to build out its managerial and clinical team, OcuTerra appointed eye care industry veteran Majid Anderesi, MD, as Vice President of Clinical and Medical Affairs in April 2022.
Allied Minds is a minority shareholder in OcuTerra and as such there is no current intention to invest any further capital in the company.
Holdings and valuation:
· Date of Last Funding Round: November 2021
· Valuation:
· Co-Investors: Various third parties
· Allied Minds' Issued and Outstanding Ownership: 17.06%
· Allied Minds' Fully-Diluted Ownership: 12.32%
4) Orbital Sidekick Inc. (OSK) (preference share holding)
OSK has developed a proprietary analytics platform based upon its hyperspectral technology that allows it to take a proprietary "chemical fingerprint" from space. Initially, OSK is addressing the very current and large concerns about the environment by focusing on potential energy pipeline failures. By employing its space-based technology, it is able to detect and identify natural gas, oil leaks and other failures much more rapidly than current monitoring techniques in a more cost-effective way while helping to minimise environmental damage.
In June 2022, the company signed a contract with one of the largest pipeline operators in
As previously announced, OSK was seeking to raise
Holdings and valuation:
· Date of Last Funding Round: April 2021
· Post-Money Valuation:
· Co-Investors: Temasek, Energy Innovation Capital and 11.2 Capital
· Allied Minds' Issued and Outstanding Ownership in respect of preference shares: 26.29%
· Allied Minds' Fully-Diluted Ownership: 23.84%
5) TouchBistro, Inc. (acquirer of TableUp, Inc.) (common shares in TouchBistro)
On 28 March 2022, Allied Minds announced that it had completed the disposal of its residual shareholding in Touch Bistro for
6) Concirrus Limited (acquirer of Spark Insights, Inc) (preferred share investment)
On 29 October 2021, Allied Minds Plc has disposed of its portfolio company, Spark Insights, Inc. to Concirrus, a private
Risk Management
The principal risks and uncertainties surrounding Allied Minds and its portfolio companies are set out in detail on pages 19 to 25 in the Risk Management section of the Strategic Report included in the 2021 Annual Report and Accounts. Such risks and uncertainties include those in connection with science and technology development or commercialisation failures; lack of profitability; inherent limitations on exclusive licenses with US universities and other federally-funded research institutions; regulatory restrictions and limitations; loss of key senior management risk; termination of critical IP licenses; the Company being deemed to be an investment company; inability to generate sufficient revenue, attract investment or generate liquidity events; lack of capital;
There have not been any significant changes in the nature of the risks set forth therein that will affect the next six months of the financial year, therefore, such risks are applicable to the remaining six months of the financial year. A copy of the 2021 Annual Report and Accounts is available on the Company's website at http://www.alliedminds.com/investor/.
Financial Review
|
For the six months ended: |
Unaudited 30 June 2022 |
|
Unaudited 30 June 2021 |
|
|
$'000 |
|
$'000 |
|
|
|
|
|
|
Revenue |
1,531 |
|
219 |
|
Cost of revenue |
(513) |
|
(119) |
|
Selling, general and administrative expenses |
(3,889) |
|
(6,344) |
|
Research and development expenses |
(1,038) |
|
(1,514) |
|
Finance cost, net |
(3,088) |
|
(3,733) |
|
Loss on investments held at fair value |
(101) |
|
(1,887) |
|
Gain on deconsolidation of subsidiary |
- |
|
14,209 |
|
Share of net loss of associates accounted for using the equity method |
- |
|
(2,362) |
|
Loss for the period |
(7,098) |
|
(1,531) |
|
Other comprehensive loss, net of tax |
(162) |
|
(206) |
|
Total comprehensive loss |
(7,260) |
|
(1,737) |
Revenue increased by
Selling, general and administrative (SG&A) expenses decreased by $2.4 million, to
Research and development (R&D) expenses decreased by $0.5 million, to
Net finance cost decreased to
Loss on investments decreased to
As a result of the above discussed factors, total comprehensive loss for the year increased by
|
As of the period ended: |
Unaudited 30 June 2022 |
|
Audited 31 December 2021 |
|
|
$'000 |
|
$'000 |
|
|
|
|
|
|
Non-current assets |
34,958 |
|
35,229 |
|
Current assets |
17,294 |
|
20,672 |
|
Total assets |
52,252 |
|
55,901 |
|
Non-current liabilities |
- |
|
213 |
|
Current liabilities |
14,902 |
|
11,033 |
|
Equity |
37,350 |
|
44,655 |
|
Total liabilities and equity |
52,252 |
|
55,901 |
Significant performance-impacting events and business developments reflected in the Group's financial position at the half year end include:
Non-current assets decreased by
o Investments at fair value represent
Current assets decreased by $3.4 million, to
o Cash and cash equivalents increased by $0.5 million to
o Trade and other receivables increased by $0.6 million due to an increase in trade receivables of
o Other financial assets have decreased by
Non-current liabilities decreased by
Current liabilities increased by
Net equity decreased by
|
For the six months ended: |
Unaudited 30 June 2022 |
|
Unaudited 30 June 2021 |
|
|
$'000 |
|
$'000 |
|
|
|
|
|
|
Net cash outflow from operating activities |
(3,267) |
|
(6,286) |
|
Net cash inflow/(outflow) from investing activities |
3,864 |
|
(14,265) |
|
Net cash (outflow)/inflow from financing activities |
(99) |
|
14,120 |
|
Net increase/(decrease) in cash and cash equivalents |
498 |
|
(6,431) |
|
Cash and cash equivalents at beginning of period |
9,710 |
|
24,489 |
|
Cash and cash equivalents at end of the period |
10,208 |
|
18,058 |
The Group's net cash outflow from operating activities of
The Group had a net cash inflow from investing activities of
The Group's net cash outflow provided by financing activities of
The Group's strategy is to manage its cash balance to focus exclusively on supporting its existing portfolio companies, noting any commitments are determined based on current facts and commitments on a case by case basis and maximising monetisation opportunities for such companies. To further minimise its exposure to risks the Group does not maintain any material borrowings or cash balances in foreign currency.
|
For the six months ended: |
Note |
Unaudited 30 June 2022 |
|
Unaudited 30 June 2021 |
|
|
|
$'000 |
|
$'000 |
|
|
|
|
|
|
|
Revenue |
2 |
1,531 |
|
219 |
|
|
|
|
|
|
|
Operating expenses: |
|
|
|
|
|
Cost of revenue |
|
(513) |
|
(119) |
|
Selling, general and administrative expenses |
|
(3,889) |
|
(6,344) |
|
Research and development expenses |
|
(1,038) |
|
(1,514) |
|
Operating loss |
|
(3,909) |
|
(7,758) |
|
Other (loss)/income: |
|
|
|
|
|
Loss on investments held at fair value |
4,11 |
(101) |
|
(1,887) |
|
Gain on deconsolidation of subsidiary |
|
- |
|
14,209 |
|
Other (loss)/income |
|
(101) |
|
12,322 |
|
Finance income |
|
13 |
|
27 |
|
Finance cost |
|
(158) |
|
(153) |
|
Finance cost from IFRS 9 fair value accounting |
9,11 |
(2,943) |
|
(3,607) |
|
Finance cost, net |
|
(3,088) |
|
(3,733) |
|
Share of net loss of associates accounted for using the equity method |
4 |
- |
|
(2,362) |
|
Loss before tax |
|
(7,098) |
|
(1,531) |
|
Taxation |
|
- |
|
- |
|
Loss for the period |
3 |
(7,098) |
|
(1,531) |
|
|
|
|
|
|
|
Other comprehensive loss: |
|
|
|
|
|
Items that may be reclassified subsequently to profit or loss: |
|
|
|
|
|
Foreign currency translation differences |
|
(162) |
|
(206) |
|
Other comprehensive loss, net of taxation |
|
(162) |
|
(206) |
|
Total comprehensive loss |
|
(7,260) |
|
(1,737) |
|
|
|
|
|
|
|
(Loss)/ Income attributable to: |
|
|
|
|
|
Equity holders of the parent |
|
(7,096) |
|
1,957 |
|
Non-controlling interests |
7 |
(2) |
|
(3,488) |
|
|
|
(7,098) |
|
(1,531) |
|
|
|
|
|
|
|
Total comprehensive (loss)/ income attributable to: |
|
|
|
|
|
Equity holders of the parent |
|
(7,258) |
|
1,751 |
|
Non-controlling interests |
7 |
(2) |
|
(3,488) |
|
|
|
(7,260) |
|
(1,737) |
|
|
|
|
|
|
|
(Loss)/ Income per share |
|
$ |
|
$ |
|
Basic |
5 |
(0.03) |
|
0.01 |
|
Diluted |
5 |
(0.03) |
|
0.01 |
|
As of the period ended: |
Note |
Unaudited 30 June 2022 |
|
Audited 31 December 2021 |
|
|
|
$'000 |
|
$'000 |
|
|
|
|
|
|
|
Non-current assets |
|
|
|
|
|
Property and equipment |
|
623 |
|
787 |
|
Investments at fair value |
4 |
33,990 |
|
33,984 |
|
Right-of-use assets |
8 |
302 |
|
414 |
|
Other financial assets |
11 |
43 |
|
44 |
|
Total non-current assets |
|
34,958 |
|
35,229 |
|
|
|
|
|
|
|
Current assets |
|
|
|
|
|
Cash and cash equivalents |
11 |
10,208 |
|
9,710 |
|
Trade and other receivables |
11 |
6,488 |
|
5,912 |
|
Other financial assets |
11 |
598 |
|
5,050 |
|
Total current assets |
|
17,294 |
|
20,672 |
|
Total assets |
|
52,252 |
|
55,901 |
|
|
|
|
|
|
|
Equity |
|
|
|
|
|
Share capital |
6 |
3,767 |
|
3,767 |
|
Treasury shares |
6 |
(738) |
|
(738) |
|
Translation reserve |
6 |
1,140 |
|
1,302 |
|
Accumulated earnings |
6 |
33,043 |
|
40,156 |
|
Equity attributable to owners of the Company |
6 |
37,212 |
|
44,487 |
|
Non-controlling interests |
7 |
138 |
|
168 |
|
Total equity |
|
37,350 |
|
44,655 |
|
|
|
|
|
|
|
Non-current liabilities |
|
|
|
|
|
Lease liability |
8 |
- |
|
213 |
|
Total non-current liabilities |
|
- |
|
213 |
|
|
|
|
|
|
|
Current liabilities |
|
|
|
|
|
Trade and other payables |
11 |
1,443 |
|
1,061 |
|
Deferred revenue |
|
5,293 |
|
4,948 |
|
Loans |
11 |
6,824 |
|
3,109 |
|
Preferred shares |
9 |
951 |
|
1,255 |
|
Lease liability |
8 |
391 |
|
660 |
|
Total current liabilities |
|
14,902 |
|
11,033 |
|
Total liabilities |
|
14,902 |
|
11,246 |
|
Total equity and liabilities |
|
52,252 |
|
55,901 |
|
|
|
|
|
|
|
|
Note |
|
Share capital |
|
Treasury shares |
|
Translation reserve $' 000 |
|
Accumulated (Deficit)/ Earnings $' 000 |
|
Total parent equity $' 000 |
|
Non-controlling interests $' 000 |
|
Total equity $' 000 |
|
|||||||||||
|
|
|
|
|
|
|
|
|
|
Shares |
|
Amount $' 000 |
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
Shares |
|
Amount $' 000 |
|
|
|
|
|
|
||||||||||||||
|
Audited Balance at 31 December 2020 |
|
|
242,187,985 |
|
3,767 |
|
- |
|
- |
|
1,343 |
|
55,440 |
|
60,550 |
|
(2,264) |
|
58,286 |
||||||||||||||
|
Total comprehensive income/(loss) for the period |
|
|
|
|
|
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Loss from continuing operations |
|
|
- |
|
- |
|
- |
|
- |
|
- |
|
1,957 |
|
1,957 |
|
(3,488) |
|
(1,531) |
||||||||||||||
|
Foreign currency translation |
|
|
- |
|
- |
|
- |
|
- |
|
(206) |
|
- |
|
(206) |
|
- |
|
(206) |
||||||||||||||
|
Total comprehensive income/(loss) for the period |
|
|
- |
|
- |
|
- |
|
- |
|
(206) |
|
1,957 |
|
1,751 |
|
(3,488) |
|
(1,737) |
||||||||||||||
|
Loss arising from change in non-controlling interest |
7 |
|
- |
|
- |
|
- |
|
- |
|
- |
|
- |
|
- |
|
(38) |
|
(38) |
||||||||||||||
|
Repurchase of ordinary shares |
6 |
|
- |
|
- |
|
(730) |
|
(181) |
|
- |
|
- |
|
(181) |
|
- |
|
(181) |
||||||||||||||
|
Deconsolidation of subsidiary |
4 |
|
- |
|
- |
|
- |
|
- |
|
- |
|
- |
|
- |
|
2,421 |
|
2,421 |
||||||||||||||
|
Equity-settled share based payments |
10 |
|
- |
|
- |
|
- |
|
- |
|
- |
|
203 |
|
203 |
|
18 |
|
221 |
||||||||||||||
|
Unaudited Balance at 30 June 2021 |
|
|
242,187,985 |
|
3,767 |
|
(730) |
|
(181) |
|
1,137 |
|
57,600 |
|
62,323 |
|
(3,351) |
|
58,972 |
||||||||||||||
|
Total comprehensive loss for the year |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Loss from continuing operations |
|
|
- |
|
- |
|
- |
|
- |
|
- |
|
(15,534) |
|
(15,534) |
|
(710) |
|
(16,244) |
||||||||||||||
|
Foreign currency translation |
|
|
- |
|
- |
|
- |
|
- |
|
(41) |
|
- |
|
(41) |
|
- |
|
(41) |
||||||||||||||
|
Total comprehensive loss for the year |
|
|
- |
|
- |
|
- |
|
- |
|
(41) |
|
(15,534) |
|
(15,575) |
|
(710) |
|
(16,285) |
||||||||||||||
|
Issuance of ordinary shares |
5 |
|
- |
|
- |
|
- |
|
- |
|
- |
|
- |
|
- |
|
(96) |
|
(96) |
||||||||||||||
|
Loss arising from change in non-controlling interest |
7 |
|
- |
|
- |
|
(2,538) |
|
(738) |
|
- |
|
- |
|
(738) |
|
- |
|
(738) |
||||||||||||||
|
Deconsolidation of subsidiary |
4 |
|
- |
|
- |
|
- |
|
- |
|
- |
|
- |
|
- |
|
3,207 |
|
3,207 |
||||||||||||||
|
Equity-settled share based payments |
10 |
|
- |
|
- |
|
- |
|
- |
|
- |
|
250 |
|
250 |
|
31 |
|
281 |
||||||||||||||
|
Audited Balance at 31 December 2021 |
|
|
242,187,985 |
|
3,767 |
|
(2,538) |
|
(738) |
|
1,302 |
|
40,156 |
|
44,487 |
|
168 |
|
44,655 |
||||||||||||||
|
Total comprehensive loss for the period |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Loss from continuing operations |
|
|
- |
|
- |
|
- |
|
- |
|
- |
|
(7,096) |
|
(7,096) |
|
(2) |
|
(7,098) |
||||||||||||||
|
Foreign currency translation |
|
|
- |
|
- |
|
- |
|
- |
|
(162) |
|
- |
|
(162) |
|
- |
|
(162) |
||||||||||||||
|
Total comprehensive loss for the period |
|
|
- |
|
- |
|
- |
|
- |
|
(162) |
|
(7,096) |
|
(7,258) |
|
(2) |
|
(7,260) |
||||||||||||||
|
Equity-settled share based payments |
10 |
|
- |
|
- |
|
- |
|
- |
|
- |
|
(17) |
|
(17) |
|
(28) |
|
(45) |
||||||||||||||
|
Unaudited Balance at 30 June 2022 |
|
|
242,187,985 |
|
3,767 |
|
(2,538) |
|
(738) |
|
1,140 |
|
33,043 |
|
37,212 |
|
138 |
|
37,350 |
||||||||||||||
|
For the six months ended: |
Note |
30 June 2022 |
|
Unaudited 30 June 2021 |
|
|
|
$'000 |
|
$'000 |
|
|
|
|
|
|
|
Cash flows from operating activities: |
|
|
|
|
|
Loss for the period |
|
(7,098) |
|
(1,531) |
|
Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
|
|
|
Depreciation |
|
324 |
|
495 |
|
Share-based compensation (reversal)/ expense |
10 |
(45) |
|
221 |
|
Loss on investments held at fair value |
4,11 |
101 |
|
1,887 |
|
Gain on deconsolidation of subsidiary |
4 |
― |
|
(14,209) |
|
Share of net loss of associate |
4 |
― |
|
2,362 |
|
Changes in working capital: |
|
|
|
|
|
(Increase)/ decrease in trade and other receivables |
|
(576) |
|
727 |
|
Decrease in other assets |
|
435 |
|
347 |
|
Increase in accrued expenses |
|
49 |
|
148 |
|
Increase/(decrease) in accounts payables |
|
334 |
|
(831) |
|
Increase in deferred revenue |
|
345 |
|
455 |
|
Increase in other liabilities |
|
83 |
|
242 |
|
Unrealised gain on foreign currency transactions |
|
(162) |
|
(206) |
|
Other finance cost |
9,11 |
2,943 |
|
3,607 |
|
Net cash used in operating activities |
|
(3,267) |
|
(6,286) |
|
|
|
|
|
|
|
Cash flows from investing activities: |
|
|
|
|
|
Purchases of property and equipment, net of disposals |
|
(48) |
|
(27) |
|
Receipt of payment for finance sub-lease |
8 |
8 |
|
78 |
|
Proceeds from sale of investments at fair value |
4 |
3,904 |
|
― |
|
Purchases of investments at fair value |
4 |
― |
|
(1,000) |
|
Cash derecognised upon loss of control over subsidiary |
4 |
― |
|
(13,316) |
|
Net cash provided by/ (used in) investing activities |
|
3,864 |
|
(14,265) |
|
|
|
|
|
|
|
Cash flows from financing activities: |
|
|
|
|
|
Proceeds from issuance of convertible notes |
|
400 |
|
― |
|
Receipt of PPP loan |
|
― |
|
257 |
|
Payment of lease liability |
8 |
(499) |
|
(565) |
|
Payments to repurchase ordinary shares |
9 |
― |
|
(181) |
|
Proceeds from issuance of preferred shares in subsidiaries |
|
― |
|
14,609 |
|
Net cash (used in)/ provided by financing activities |
|
(99) |
|
14,120 |
|
|
|
|
|
|
|
Net increase/ (decrease) in cash and cash equivalents |
|
498 |
|
(6,431) |
|
Cash and cash equivalents at beginning of period |
|
9,710 |
|
24,489 |
|
Cash and cash equivalents at end of period |
|
10,208 |
|
18,058 |
Allied Minds Group comprises of Allied Minds plc and its subsidiaries ("Allied Minds", the "Group" or the "Company"). The Company is publicly listed on the Main Market of the London Stock Exchange ("LSE"). Allied Minds plc is engaged in the development of various technologies for commercial applications. As of 30 June 2022, Allied Minds Group comprised of three legal subsidiaries, which included one active portfolio company that is currently majority owned and controlled, and therefore fully consolidated in the Company's consolidated financial statements prepared in accordance with
Certain portfolio companies have entered into agreements with universities, scientists, and US federal research institutions to develop and commercialise products. In exchange for licenses, time, and expertise already provided, certain universities and/or scientists received an equity ownership in such companies. The cash contributed by Allied Minds is used to fund additional research and to create a management structure and operations.
This condensed consolidated unaudited interim financial report for the half-year reporting period ended 30 June 2022 has been prepared in accordance with the
The interim report does not include all of the notes of the type normally included in an annual financial report. Accordingly, this report is to be read in conjunction with the annual report for the year ended 31 December 2021, which has been prepared in accordance with
These condensed unaudited interim financial statements do not comprise statutory accounts within the meaning of section 434 (3) of the Companies Act 2006. Statutory accounts for the year ended 31 December 2021 were approved by the board of directors and delivered to the Registrar of Companies. The report of the auditors on those accounts was unqualified, did not contain an emphasis of matter paragraph and did not contain any statement under section 498 (2) - (3) of the Companies Act 2006.
Subsidiaries are fully consolidated from the date of acquisition, being the date on which the Group obtains control and continue to be consolidated until the date when such control ceases. The financial information of the subsidiaries is prepared for the same reporting period as the parent Company, using consistent accounting policies. All intra-group balances, transactions, unrealised gains and losses resulting from intra-group transactions and dividends are eliminated in full.
Investments in associates where it is demonstrated that the Group exercises significant influence over the entity are equity accounted in line with IAS 28.
Non-controlling interests (''NCI'') are measured at their proportionate share of the acquiree's identifiable net assets at the acquisition date. Changes in the Group's interest in a subsidiary that do not result in a loss of control are accounted for as equity transactions.
When the Group loses control over a subsidiary, it derecognises the assets and liabilities of the subsidiary, and any related NCI and other components of equity. Any resulting gain or loss is recognised in profit or loss. Any interest retained in the former subsidiary is measured at fair value when control is lost.
The financial information presented in these half-yearly results has been prepared under the historical cost convention. The presentational currency adopted by Allied Minds is US Dollar ('$') as this is the functional currency all of the entities in the Group except for the parent company, Allied Minds Plc, which has a Sterling ('GBP') functional currency. In preparing these interim financial statements, management has made judgements, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets and liabilities, income and expense. Actual results may differ from these estimates.
The significant judgements made by management in applying the Group's accounting policies and the key sources of estimation uncertainty were the same as those that applied to the consolidated financial information included in the Group annual report and accounts as at and for the year ended 31 December 2021.
The Directors have taken proactive cost management measures that include reduction in expenses of the management function of the head office at the parent level. They have also decided to focus exclusively on supporting the five existing portfolio companies, albeit do not make or have and enforceable financial or working capital commitments, and maximising monetisation opportunities for portfolio company interests, and not to deploy any capital into any new portfolio companies. In the event of successful monetisation events from the sale of portfolio companies or portfolio company interests, the Directors anticipate distributing the net proceeds to shareholders, after due consideration of potential follow-on investment opportunities within the existing portfolio and working capital requirements. The Directors expect this strategy to take at least two years to be fully implemented, and as a matter of good governance, will continue to keep this strategy under review at appropriate intervals. They have prepared trading and cash flow forecasts for the parent through 2025. Reflecting this revised strategy, although the Group is currently loss making and is likely to continue to be so, at least in the short term, after making enquiries and considering the impact of risks and opportunities on expected cash flows, and given the fact that the Group has
Though the majority of the Company's operations are in
The Directors have also put in measures to mitigate against the risks to the business such as the continued impact of COVID-19. The situation in
The condensed consolidated financial statements are not audited and the results for the six months ended 30 June 2022 are not necessarily indicative of results for future operating periods.
Certain financial information has been extracted from the annual report and accounts as at and for the period ended 31 December 2021 and has been included for comparative purposes in this half-yearly report.
These interim financial statements are unaudited and were approved by the Board of Directors and authorised for issue on 29 September 2022 and are available on the Company's website at www.alliedminds.com under "Investors - Reports and Presentations".
Except as described below, the accounting policies applied by the Group in these half-yearly results are the same as those which formed the basis of the 2021 Annual Report and Accounts, with the exception of the new standards the Group adopted as of 1 January 2022, included below.
The changes in accounting policies are also expected to be reflected in the Group's consolidated financial statements as of and for the year ending 31 December 2022.
Newly adopted standards
The following are amended or new standards and interpretations that may impact the Group. The Group is finalising the required disclosures, which includes an assessment of the impact of the new guidance on our financial position and results of operations. The adoption of the proposed changes is not expected to have a material effect on the financial statements unless otherwise indicated:
|
Effective date |
New standards or amendments |
|
1 January 2022
|
Onerous contracts - Cost of Fulfilling a Contract (Amendments to IAS 37) |
|
|
References to Conceptual Framework (Amendments to IFRS 3) |
|
|
Property, Plant and Equipment: Proceeds before Intended Use (amendments to IAS16 |
|
|
Annual Improvements to IFRS Standards 2018-2020 (Amendments to IFRS 1, IFRS 9, IFRS 16 and IAS 41) |
Standards issued not yet effective
Other new standards and interpretations yet to be adopted, for which the Company does not expect to have a material impact on its financial statements include:
|
1 January 2023 |
IFRS 17 Insurance Contracts |
|
1 January 2023 |
Disclosure of Accounting Policies (Amendments to IAS 1 and IFRS Practice Statement 2) |
|
1 January 2023 |
Classification of Liabilities as Current or Non-current (Amendments to IAS 1) |
|
1 January 2023 |
Definition of Accounting Estimates (Amendments to IAS 8) |
|
1 January 2023 |
Deferred Tax related to Assets and Liabilities arising from a Single Transaction (Amendments to IAS 12) |
Revenue recorded in the statement of comprehensive loss consists of the following:
|
For the period ended: |
|
Unaudited 30 June 2022 |
|
Unaudited 30 June 2021 |
|
|
|
$'000 |
|
$'000 |
|
|
|
|
|
|
|
Service revenue |
|
1,531 |
|
219 |
|
Total revenue in consolidated statement of income/(loss) |
|
1,531 |
|
219 |
Revenue is measured based on the consideration specified in a contract with a customer. The Group recognises revenue when it transfers control over a good or service to a customer. The Group disaggregates contract revenue based on the transfer of control of the underlying performance obligations and for both accounting period the performance obligation has been satisfied over time for all revenue.
For management purposes, the Group's principal operations are organised in three reportable segments:
(i) Early stage companies - subsidiary businesses that are in the early stage of their lifecycle characterised by incubation, research and development activities; and
(ii) Later stage companies - subsidiary businesses that have substantially advanced with or completed their research and development activities, are closer in their lifecycle to commercialisation, and/or have a potential of realising material return on investment through a future liquidity event;
(iii) Minority holdings companies reflect the activity related to portfolio companies other than consolidated subsidiary businesses where the Group has made a minority investment and does not control or exercise joint control over the financial and operating policies of those entities. This segment will only include the results of entities which were deconsolidated during the accounting period. No subsidiaries were deconsolidated in the first half of 2022. As of 30 June 2021, this operating segment included OcuTerra Therapeutics, Inc. profit and loss for the period up to deconsolidation on 27 April 2021.
The Group's chief operating decision maker ("CODM") reviews internal management reports on these operating segments at least quarterly in order to make decisions about resources to be allocated to the segment and to assess its performance.
Other operations include the management function of the head office at the parent level of Allied Minds.
The following provides detailed information of the Group's reportable segments:
|
For the six months ended 30 June 2022: |
|
||||||||||||||||||||
|
|
|
|
|
|
|
|
$'000 |
||||||||||||||
|
|
|
|
|
|
|
|
Later |
|
Other |
|
Consolidated |
||||||||||
|
|
|
|
|
|
|
|
Stage |
|
|
Operations |
|
||||||||||
|
Statement of Comprehensive Loss |
|
|
|
|
|
||||||||||||||||
|
|
Revenue |
|
1,531 |
|
1,531 |
1,531 |
|
― |
|
1,531 |
|||||||||||
|
|
Cost of revenue |
|
|
(513) |
(513) |
|
― |
|
(513) |
||||||||||||
|
|
Selling, general and administrative expenses |
|
(1,058) |
|
(2,831) |
|
(3,889) |
||||||||||||||
|
|
Research and development expenses |
|
(1,038) |
|
― |
|
(1,038) |
||||||||||||||
|
|
Other income |
|
298 |
|
(399) |
|
(101) |
||||||||||||||
|
|
Finance income/(cost), net |
|
866 |
|
(3,954) |
|
(3,088) |
||||||||||||||
|
|
|
Income/(Loss) for the period |
|
86 |
|
(7,184) |
|
(7,098) |
|||||||||||||
|
|
Other comprehensive income/(loss) |
|
― |
|
(162) |
|
(162) |
||||||||||||||
|
|
|
Total comprehensive income/((loss) |
|
86 |
|
(7,346) |
|
(7,260) |
|||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
Total comprehensive income attributable to: |
|
|
|
|
|
|
|
|||||||||||||
|
|
|
Equity holders of the parent |
|
88 |
|
(7,346) |
|
(7,258) |
|||||||||||||
|
|
|
Non-controlling interests |
|
(2) |
|
― |
|
(2) |
|||||||||||||
|
|
|
Total comprehensive income/ (loss) |
|
86 |
|
(7,346) |
|
(7,260) |
|||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|||||||||||||||||||||||||||
|
For the six months ended 30 June 2021: |
$'000 |
|
||||||||||||||||||||||||||||
|
|
|
|
|
|
|
Early stage |
|
Later stage |
|
Minority |
|
Other |
|
Consolidated |
|
|||||||||||||||
|
|
|
|
|
|
|
Stage |
|
Stage |
|
Holdings
|
|
operations |
|
|
||||||||||||||||
|
Statement of Comprehensive Loss |
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
|
|
Revenue |
|
|
250 |
― |
|
219 |
|
― |
|
― |
|
219 |
|
||||||||||||||||
|
|
Cost of revenue |
|
|
― |
|
(119) |
|
― |
|
― |
|
(119) |
|
|||||||||||||||||
|
|
Selling, general and administrative expenses |
(43) |
|
(1,337) |
|
(1,524) |
|
(3,440) |
|
(6,344) |
|
|||||||||||||||||||
|
|
Research and development expenses |
(428) |
|
(966) |
|
(120) |
|
― |
|
(1,514) |
|
|||||||||||||||||||
|
|
Other income |
― |
|
― |
|
― |
|
12,322 |
|
12,322 |
|
|||||||||||||||||||
|
|
Finance income/(cost), net |
(6) |
|
12,985 |
|
(11,060) |
|
(5,652) |
|
(3,733) |
|
|||||||||||||||||||
|
|
Share of net loss of associates accounted for using the equity method |
― |
|
― |
|
― |
|
(2,362) |
|
(2,362) |
|
|||||||||||||||||||
|
|
|
(Loss) for the period |
(477) |
|
10,782 |
|
(12,704) |
|
868 |
|
(1,531) |
|
||||||||||||||||||
|
|
Other comprehensive income/(loss) |
― |
|
― |
|
― |
|
(206) |
|
(206) |
|
|||||||||||||||||||
|
|
|
Total comprehensive income/((loss) |
(477) |
|
10,782 |
|
(12,704) |
|
662 |
|
(1,737) |
|
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
|
Total comprehensive income attributable to: |
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
|
|
|
Equity holders of the parent |
30 |
|
10,619 |
|
(9,560) |
|
868 |
|
1,957 |
|
||||||||||||||||||
|
|
|
Non-controlling interests |
(507) |
|
163 |
|
(3,144) |
|
― |
|
(3,488) |
|
||||||||||||||||||
|
|
|
Total comprehensive income |
(477) |
|
10,782 |
|
(12,704) |
|
867 |
|
(1,531) |
|
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
As of the period ended 30 June 2022: |
|
|||||
|
|
|
|||||
|
|
|
|||||
|
|
|
Later stage |
|
Other operations |
|
Consolidated |
|
Statement of Financial Position |
|
|
|
|
|
|
|
Non-current assets |
|
695 |
|
34,263 |
|
34,958 |
|
Current assets |
|
6,363 |
|
10,931 |
|
17,924 |
|
Total assets |
|
7,058 |
|
45,194 |
|
52,252 |
|
Non-current liabilities |
|
― |
|
― |
|
― |
|
Current liabilities |
|
(16,014) |
|
1,112 |
|
(14,902) |
|
Total liabilities |
|
(16,014) |
|
1,112 |
|
(14,902) |
|
Net assets/(liabilities) |
|
(8,956) |
|
46,306 |
|
37,350 |
|
As of the period ended 30 June 2021: |
|
|||||
|
|
|
|||||
|
|
|
|||||
|
|
|
Later stage |
|
Other operations |
|
Consolidated |
|
Statement of Financial Position |
|
|
|
|
|
|
|
Non-current assets |
|
820 |
|
34,409 |
|
35,229 |
|
Current assets |
|
6,262 |
|
14,410 |
|
20,672 |
|
Total assets |
|
7,082 |
|
48,819 |
|
55,901 |
|
Non-current liabilities |
|
(75) |
|
(138) |
|
(213) |
|
Current liabilities |
|
(12,820) |
|
1,787 |
|
(11,033) |
|
Total liabilities |
|
(12,895) |
|
1,649 |
|
(11,246) |
|
Net assets/(liabilities) |
|
(5,813) |
|
50,468 |
|
44,655 |
Group Subsidiaries, associates and investments
As of 30 June 2022, Allied Minds has five portfolio companies, including subsidiaries, associates and investments, and two holding companies. As at the 30 June 2022 the investments in each of the companies and the accounting treatment is summarized below:
|
Company name |
Financial instruments held |
Accounting treatment of financial instruments |
|
Allied Minds LLC |
Ordinary shares |
Consolidated by the group in line with IFRS 10 and following management assessment of significant control.
|
|
Allied Minds Securities Corp. |
Ordinary shares |
Consolidated by the group in line with IFRS 10 and following management assessment of significant control.
|
|
BridgeComm, Inc. |
Ordinary share capital and preferred shares |
Consolidated by the group in line with IFRS 10 and following management assessment of significant control. Preferred shares are eliminated on consolidation between group companies, preferred shares held by third parties are fair valued through profit and loss under IFRS 9.
|
|
Concirrus, LTD |
Preferred shares |
The Group has a minority stake in the investment and does not have significant influence over the company. The investment in preferred shares is accounted for at fair value through the profit and loss under IFRS 9.
|
|
OcuTerra Therapeutics, Inc. |
Ordinary share capital and preferred shares |
The Group does not have significant influence over the company. The investment in ordinary shares is accounted for at fair value through the profit and loss under IFRS 9. Preferred share holdings are accounted for at fair value through profit and loss as investments held by the Group under IFRS 9.
|
|
Federated Wireless, Inc. |
Ordinary share capital and preferred shares |
The ordinary share capital ownership means that the group has significant influence but not control over the entity. Therefore, the investment in ordinary shares is accounted for by the equity method of accounting under IAS 28. Preferred share holdings are accounted for at fair value through profit and loss as investments held by the Group under IFRS 9. |
|
Orbital sidekick, Inc. |
Preferred shares |
No ordinary shares are owned by Allied Minds and the directors have judged, at the year end, that the group does not have significant influence over the entity through its preferred share holding. Preferred share holdings are accounted for at fair value through profit and loss as investments held by the Group under IFRS 9. |
At 30 June 2022, the Group has one associate, Federated Wireless, which is material to the Group and is equity accounted.
Federated Wireless: As of 31 December 2021, Allied Minds' ownership percentage went from 43.11% to 42.72% and the investment in Federated Wireless continued to be subject to the equity method accounting. In accordance with IAS 28, the Company's investment was adjusted by the share of losses generated by Federated Wireless subsequent to the date of deconsolidation up to the point where the investment in Federated was reduced to a zero balance.
As of 30 June 2022, Allied Minds' ownership percentage went from 42.72% to 27.04% and continues to be subject to the equity method accounting and no further adjustments were made to the investment balance at 30 June 2022. If Federated Wireless subsequently reports profits, Allied Minds will resume recognising its share of those profits only after its share of the profits equals the share of losses not recognised.
|
|
|
|
|
|
|
|
|
|
|
Ownership percentage |
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
Location |
|
|
30 June 2022 |
|
31 December 2021 |
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
Federated Wireless, Inc. |
|
|
|
|
27.04% |
|
42.72% |
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
30 June 2022 |
|
31 December 2021 |
|||
|
|
|
|
|
|
|
|
|
|
|
$'000 |
|
$'000 |
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
Group's interest in net assets of investee, beginning of period |
|
|
|
|
― |
|
― |
||||||||
|
Share of loss from continuing operations |
|
|
|
|
― |
|
― |
||||||||
|
Carrying amount for equity accounted investees |
|
― |
|
― |
|||||||||||
|
Unrecognised share of losses in associate |
|
(66,005) |
|
(53,169) |
|||||||||||
|
Total outstanding |
|
(66,005) |
|
(53,169) |
|||||||||||
Investments at fair value
The Group's investments at fair value represent securities of portfolio companies where Allied Minds holds preferred shares or a minority stake in those companies. These investments are initially measured at fair value through profit or loss and are subsequently re-measured at fair value at each reporting date and on derecognition.
Federated Wireless: The Company's investment at fair value in Federated Wireless has changed from $14.2 million, as reported at 31 December 2021, to $18.6 million at 30 June 2022. The increase in investment balance primarily relates to the conversion of Federated Wireless's SAFE of $4.3 million into preferred shares upon the closing of the Series D funding and $0.1 million in the IFRS 9 fair value accounting during the period. Series A and Series C preferred shares were also adjusted following the anti-dilution protection option in the event of a down round financing. As such, this resulted in 258,839 more shares, Series A and C combined, issued to Allied Minds.
Orbital Sidekick: On 6 April 2018, Allied Minds made an investment in Orbital Sidekick, a company developing capabilities in aerial and space-based hyperspectral imaging and analytics, initially for the oil and gas industry. Allied Minds has significant influence over financial and operating policies of the investee by virtue of its large, albeit minority, stake in the company and its representation on the entity's board of directors. Allied Minds only held shares of preferred stock in Orbital Sidekick. The preferred shares held by Allied Minds are not equity-like and therefore these fall under the guidance of IFRS 9 and will be treated as a financial asset held at fair value where all movements to the value of Allied Minds' share in the preferred stock will be recorded through the Consolidated Statements of Comprehensive Loss.
On 13 April 2021, Orbital Sidekick, Inc. ("OSK") completed the closing of its $16 million Series A funding round led by Temasek, an investment company headquartered in
TouchBistro: On 6 April 2018, Allied Minds made an investment in TableUp, a software provider enabling end-to-end transparency through the restaurant supply chain to enable more effective inventory and operations management. On 5 August 2020, TableUp was acquired by TouchBistro, Inc. ("TouchBistro") in which TouchBistro acquired 100% of the shares of TableUp in exchange for the issuance of TouchBistro common shares to the shareholders of TableUp. As such, Allied Minds's investment in preferred stock, along with the convertible note, was fully converted into common shares in TouchBistro. Allied Minds' ownership percentage was 1.40% at 31 December 2020.
On 28 March 2022, Allied Minds has completed the disposal of its residual shareholding in TouchBistro for $5.5 million CAD ($4.3 million USD) in line with its strategy of monetising its investment portfolio. Of the sale proceeds, $3.9 million has been received at the time of the sale. On 23 August 2022 the remaining TouchBistro shares were released from the escrow account and as a result Allied Minds received $0.4 million in proceeds from the pre-arranged sale of these shares.
OcuTerra Therapeutics: As of April 2021, OcuTerra Therapeutics was deconsolidated from the Group's financial statements as a result of the first closing of its Series B Preferred Stock financing round. On that date Allied Minds' issued and outstanding ownership percentage dropped from 62.67% to 27.58%.
Consequently, since the Company no longer held a majority of the voting rights in OcuTerra Therapeutics and did not hold a majority on its board of directors, Allied Minds did not exercise effective control over OcuTerra Therapeutics. However, even after the transaction, Allied Minds was able to exercise significant influence over the entity by virtue of its large, albeit minority, stake in the company and its representation on the OcuTerra Therapeutics's board of directors. As such, only the profits and losses generated by OcuTerra Therapeutics through April 2021 were included in the Group's Consolidated Statements of Comprehensive Loss. Upon the date of deconsolidation, Allied Minds recognised an investment in OcuTerra Therapeutics related to its common shares of $2.4 million. Series A Preferred Stock and Series B Preferred Stock (collectively the "OcuTerra Therapeutics Preferred Stock") held by Allied Minds are not equity-like and therefore these fall under the guidance of IFRS 9 and will be treated as a financial asset held at fair value where all movements to the value of Allied Minds' share in the preferred stock will be recorded through the Consolidated Statements of Comprehensive Loss. At the date of deconsolidation these were classified as an investment at fair value of $3.3 million. The fair value of the investment in associate at the date of deconsolidation was based on the value implied from the third party funding round which lead to the loss of control. This is a market based valuation approach. As a result of the deconsolidation, Allied Minds recorded an unrealised gain of $14.2 million in the Consolidated Statements of Comprehensive Loss. The gain was calculated by taking the difference between the fair value of the interest retained in the former subsidiary at the date control is lost less the carrying amount of net assets adjusted for the non-controlling interests of the former subsidiary.
On 21 June 2021, OcuTerra completed the third closing of the same Series B financing and as a result, Allied Minds' ownership dropped to 18.98% of the issued and outstanding shares. In addition, Allied Minds does not have Board of Directors representation and therefore it is limited in its participation in operating and capital. Based on these factors management have judged that Allied Minds cannot alone impact the policy making processes of the company and there are no other material transaction between the investor and investee. It has therefore been determined, Allied Minds no longer has significant influence over the investee and the investment does not meet the definition of an associate under IAS 28 at this date. As such, Allied Minds' share of common stock is accounted as an investment at fair value in accordance with IFRS 9 for the period beyond 21 June 2021.
Allied Minds' investment in common shares was adjusted by the share of loss of $2.4 million generated by OcuTerra Therapeutics for the period 27 April through 21 June 2021. This reduced the investment in OcuTerra to a zero balance. At 21 June 2021, the investment in OcuTerra's common shares was accounted as an investment at fair value in accordance with IFRS 9. The investment in OcuTerra's common shares was subsequently measured at $2.6 million from $nil at 21 June 2021. This resulted in a gain through profit and loss in relation to the fair value of this amount.
As of 30 June 2022, Allied Minds investment held at fair value related to its Preferred Shares and Common Shares in OcuTerra was valued at $5.0 million (31 December 2021: $6.3 million).
|
|
|
|
|
|
|
|
|
|
|
Ownership percentage |
|||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
Location |
|
|
30 June 2022 |
|
31 December 2021 |
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
OcuTerra Therapeutics, Inc. |
|
|
|
17.06% |
|
17.06% |
|
||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
30 June 2022 |
|
31 December 2021 |
||||||||||
|
|
|
|
|
|
|
|
|
|
$'000 |
|
$'000 |
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Group's interest in net assets of investee, beginning of period |
|
|
|
― |
|
― |
|||||||||||||||
|
Addition in the year |
|
|
|
|
― |
|
2,362 |
||||||||||||||
|
Share of loss from continuing operations |
|
|
|
|
― |
|
(2,362) |
||||||||||||||
|
Carrying amount for equity accounted investees |
|
― |
|
― |
|||||||||||||||||
|
Unrecognised share of losses in associate |
|
― |
|
(1,406) |
|||||||||||||||||
|
Total outstanding |
|
― |
|
(1,406) |
|||||||||||||||||
Concirrus: On 29 October 2021, Allied Minds Plc has disposed of its portfolio company, Spark Insights, Inc. to Concirrus, a private
Those investments are presented in the below table:
|
|
30 June 2022 |
Disposals |
(Loss)/gain from IFRS 9 fair value accounting |
Additions |
31 December 2021 |
|
|
$'000 |
$'000 |
$'000 |
$'000 |
$'000 |
|
Federated Wireless, Inc. |
18,603 |
― |
166 |
4,283 |
14,154 |
|
Orbital Sidekick, Inc. |
9,761 |
― |
1,233 |
― |
8,528 |
|
TouchBistro, Inc.(2) |
― |
(4,321) |
(9) |
― |
4,330 |
|
OcuTerra Therapeutics, Inc. |
5,003 |
― |
(1,273) |
― |
6,276 |
|
Concirrus, LTD(1) |
623 |
― |
― |
― |
696 |
|
Total investments at fair value |
33,990 |
(4,321) |
117 |
4,283 |
33,984 |
(1) Concirrus balance is adjusted by foreign currency changes for the period. No fair market value changes were noted as of 30 June 2022.
(2) On 28 March 2022, Allied Minds has completed the disposal of its residual shareholding in TouchBistro for $4.3 million USD. Of the sale proceeds, $3.9 million had been received at the time of the sale and $0.4 million was received subsequent to period end when shares held in escrow were released. This account was reclassified to current assets in line with the nature of this balance.
Allocation Model Inputs
The following presents the quantitative information about the significant unobservable inputs used in the fair value measurement of the Group's financial assets:
|
As of the period ended: |
|
30 June 2022 |
|
31 December 2021 |
|
Volatility |
|
50.4%-70.9% |
|
51.8%-81.2% |
|
Time to liquidity (years) |
|
1.0 - 3.0 |
|
0.75 - 2.75 |
|
Risk-free rate |
|
2.80% - 2.99% |
|
0.29% - 0.89% |
|
IPO/M&A/Sale Probability |
|
0%/ 100%/ n/a |
|
0%/ 100%/ n/a |
|
|
|
|
|
|
Sensitivity Analysis
The following summarises the sensitivity from the assumptions made by the Company in respect to the unobservable inputs used in the fair value measurement of the Group's financial assets:
|
As of the period ended: |
|
|
30 June 2022 |
31 December 2021 |
|
|
|
|
$'000 |
$'000 |
|
Input |
Sensitivity range |
|
Financial assets increase/(decrease) |
|
|
Enterprise Value |
-2% |
|
(710) |
(780) |
|
|
+2% |
|
887 |
677 |
|
Volatility |
-10% |
|
446 |
171 |
|
|
+10% |
|
(85) |
(79) |
|
Time to Liquidity |
-6 months |
|
409 |
534 |
|
|
+6 months |
|
(212) |
(1,756) |
|
Risk-Free Rate (1) |
-0.28%/-0.23% |
|
409 |
809 |
|
|
0.06% /0.18% |
|
(212) |
(465) |
(1) Risk-free rate is a function of the time to liquidity input assumption.
Valuation methodology
The fair value is derived using the option pricing model ("OPM"), the Probability-Weighted Expected Return Method ("PWERM") or a hybrid of the two.
The key inputs into these valuation models include the equity value of the portfolio company, the term of the instrument, risk free rate and volatility.
The valuation methodologies utilised for determining the equity value include market approach, income approach or cost approach or hybrid of these approaches. Other methodologies such as asset based and cash in are also utilised where deemed appropriate. It is noted that in the current year none of the equity values were determined using the income approach.
Other valuation approaches
In certain cases, the value of a portfolio company is determined using a market instead of income- based approach.
Where there has been a third party funding round in the year this has been used as the implied value of the portfolio company or comparable guideline public companies or comparable transactions, adjusted for indexation where this is deemed to be appropriate.
Whilst the Board considers the methodologies and assumptions adopted in the valuation are supportable, reasonable and robust, because of the inherent uncertainty of valuation, those estimated values may differ significantly from the values that would have been used had a ready market for the investment existed and the differences could be significant.
PWERM and OPM
The principal methods the Group applies for allocation of value are the PWERM, the OPM as well as a hybrid of the two. These models take assumptions such as the equity values, term of the instruments, risk free rate and volatility to determine the fair value of each share class.
The PWERM estimates the value of equity securities based on an analysis of various discrete future outcomes, such as an IPO, merger or sale, dissolution, or continued operation as a private enterprise until a later exit date. The equity value today is based on the probability-weighted present values of expected future investment returns, considering each of the possible outcomes available to the enterprise, as well as the rights of each security class. The key judgement relates to probability weighting of the scenarios.
The OPM treats common stock or derivatives thereof as call options on the enterprise's value or overall equity value. The value of a security is based on the optionality over and above the value securities that are senior in the capital structure (e.g. preferred stock), considering the dilutive effects of subordinate securities. In the OPM, the exercise price is based on a comparison with the overall equity value rather than per-share value.
The calculation of basic and diluted earnings per share has been calculated by dividing the loss for the period attributable to ordinary shareholders of $7.1 million (HY21: income of $2.0 million), by the weighted average number of ordinary shares outstanding of 239,650,273 (HY21: 242,163,396 ) during the six-month period ended 30 June 2022:
|
For the six months ended: |
Unaudited 30 June 2022 |
|
Unaudited 30 June 2021 |
||||
|
|
Basic |
|
Diluted |
|
Basic |
|
Diluted |
|
|
$'000 |
|
$'000 |
|
$'000 |
|
$'000 |
|
|
|
|
|
|
|
|
|
|
(Loss)/ Income for the year attributed to the ordinary shareholders |
(7,096) |
|
(7,096) |
|
1,957 |
|
1,957 |
|
(Loss)/ Income for the year attributed to the ordinary shareholders |
(7,096) |
|
(7,096) |
|
1,957 |
|
1,957 |
|
For the six months ended: |
30 June 2022 |
30 June 2021 |
|||
|
|
Basic |
Diluted |
Basic |
Diluted |
|
|
Issued ordinary shares |
239,650,273 |
239,650,273 |
242,163,396 |
242,163,396 |
|
|
Weighted average ordinary shares |
239,650,273 |
239,650,273 |
242,163,396 |
242,163,396 |
|
(Loss)/ income per share:
|
For the six months ended: |
Unaudited 30 June 2022 |
|
Unaudited 30 June 2021 |
||
|
|
Basic |
Diluted |
|
Basic |
Diluted |
|
|
$ |
$ |
|
$ |
$ |
|
|
|
|
|
|
|
|
(Loss)/ income per share |
(0.03) |
(0.03) |
|
0.01 |
0.01 |
Awards granted under the LTIP (as defined below) are subject to vesting requirements that are either based on performance conditions and continued services or time conditions only. Per IAS 33, only awards that are subject to performance criteria are considered contingently issuable and therefore represent the only class of potentially dilutive ordinary shares. Based upon information available at the end of the reporting period, no portion of these performance-based awards under the LTIP has vested. Consequently, there are no potentially dilutive shares outstanding at the period end.
The table below explains the composition of share capital:
|
As of the period ended: |
30 June 2022 |
|
31 December 2021 |
|
|
$'000 |
|
$'000 |
|
|
|
|
|
|
Equity |
|
|
|
|
Share capital, £0.01 par value, issued and fully paid |
3,767 |
|
3,767 |
|
Treasury shares |
(738) |
|
(738) |
|
Translation reserve |
1,140 |
|
1,302 |
|
Accumulated earnings |
33,043 |
|
40,156 |
|
Equity attributable to owners of the Company |
37,212 |
|
44,487 |
|
Non-controlling interests |
138 |
|
168 |
|
Total equity |
37,350 |
|
44,655 |
In 2021 ALM's Board of Directors (the "Board") approved a programme to buy back up to $3.0 million of the Group's shares ("Buyback Programme"). The Buyback Programme ran from the date of the announcement to 6 October 2021. In 2021, the company repurchased 2,537,712 of its own shares for a total value of $737,678.
The following summarises the changes in the non-controlling ownership interest in subsidiaries by reportable segment, calculated on the basis of percentage ownership of non-controlling interest in voting stock on an as converted basis, excluding liability classified preferred shares:
|
|
|
|
Later stage |
|
Consolidated |
|
|
|
|
$'000 |
|
$'000 |
|
Non-controlling interest as of 31 December 2021 |
|
|
168 |
|
168 |
|
Share of comprehensive income |
|
|
(2) |
|
(2) |
|
Equity-settled share based payments |
|
|
(28) |
|
(28) |
|
Non-controlling interest as of 30 June 2022 |
|
|
138 |
|
138 |
Right of use asset
|
|
Right of use assets |
|
|
|
$000s |
|
|
Balance at 1 January 2021 |
414 |
|
|
Depreciation |
(112) |
|
|
Balance at 30 June 2022 |
302 |
|
Lease liability
|
|
Total lease liability |
|
|
$000s |
|
Balance at 1 January 2021 |
873 |
|
Cash paid |
(499) |
|
Interest expense |
17 |
|
Balance at 30 June 2022 |
391 |
Amounts were arrived at using the contractual minimal lease payments, present valued using the applicable incremental borrowing rate of 5.50%.
During 2019, the Group relocated its corporate headquarters and as a result it sub-leased the office space that has been presented as part of a right-of-use asset. As the sub-lease is for all of the remaining useful economic life of the right-of-use asset, the sub-lease is classified as a finance lease.
At 30 June 2022, BridgeComm Inc. had outstanding preferred shares which were classified as subsidiary preferred shares in current liabilities in accordance with IFRS 9 as BridgeComm has a contractual obligation to deliver cash or other assets to the holders under certain future liquidity events, and/or a requirement to deliver an uncertain number of common shares upon conversion. The preferred shares do not contain mandatory dividend rights. The preferred shares are convertible into common stock of the subsidiary at the option of the holder and are mandatorily convertible into common stock of the subsidiary upon a qualified public offering at or above certain value and gross proceeds specified in the agreements or upon the vote of the holders of a majority of the subsidiary preferred shares. Under certain scenarios the number of common stock shares receivable on conversion will change. The Group has elected not to bifurcate the variable conversion feature as a derivative liability, but account for the entire instrument at fair value through the income statement.
The preferred shares are entitled to a vote with holders of common stock on an as converted basis. The holders of the preferred shares are entitled to a liquidation preference amount in the event of a liquidation or a deemed liquidation event of the respective subsidiary. The Group recognises the subsidiary preferred shares balance upon the receipt of cash financing, and records the change in its fair value for the respective reporting period through profit and loss. Preferred shares are not allocated shares of the subsidiary losses.
The following summarises the subsidiary preferred shares balance:
|
As of the period ended: |
|
30 June 2022 |
|
|
|
Finance (income)/cost from IFRS 9 fair value accounting |
|
|
|
31 December 2021 |
||||
|
|
|
$'000 |
|
Disposals |
|
$'000 |
|
Additions |
|
$'000 |
||||
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
BridgeComm |
|
951 |
|
― |
|
(304) |
|
― |
|
1,255 |
||||
|
|
Total subsidiary preferred shares |
|
951 |
|
― |
|
(304) |
|
― |
|
1,255 |
|||
The redemption is conditional on occurrence of uncertain future events beyond the control of the Group. The amount that would be payable in case of such events is as follows:
|
As of the period ended: |
30 June 2022 |
|
31 December 2021 |
|
|
$'000 |
|
$'000 |
|
|
|
|
|
|
BridgeComm |
950 |
|
1,260 |
|
Total liquidation preference |
950 |
|
1,260 |
Valuation methodology
The fair value is derived using the option pricing model ("OPM"), the Probability-Weighted Expected Return Method ("PWERM") or a hybrid of the two.
The key inputs into these valuation models include the equity value of the subsidiary, the term of the instrument, risk free rate and volatility.
The valuation methodologies utilised for determining the equity value include the market approach, income approach or cost approach or hybrid of these approaches. Other methodologies such as asset based are also utilised where deemed appropriate. It is noted that in the current year none of the equity values were determined using the income approach.
Where there has been a third party funding round in the year this has been used as the implied value of the portfolio company or comparable guideline public companies or comparable transactions, adjusted for indexation where this is deemed to be appropriate.
Whilst the Board considers the methodologies and assumptions adopted in the valuation are supportable, reasonable and robust, because of the inherent uncertainty of valuation, those estimated values may differ significantly from the values that would have been used had a ready market for the investment existed and the differences could be significant.
PWERM and OPM
The principal methods the Group applies for allocation of value are the PWERM, the OPM as well as a hybrid of the two. These models take assumptions such as the equity values, term of the instruments, risk free rate and volatility to determine the fair value of each share class.
The PWERM estimates the value of equity securities based on an analysis of various discrete future outcomes, such as an IPO, merger or sale, dissolution, or continued operation as a private enterprise until a later exit date. The equity value today is based on the probability-weighted present values of expected future investment returns, considering each of the possible outcomes available to the enterprise, as well as the rights of each security class. The key judgement relates to probability weighting of the scenarios.
The OPM treats common stock or derivatives thereof as call options on the enterprise's value or overall equity value. The value of a security is based on the optionality over and above the value securities that are senior in the capital structure (e.g. preferred stock), considering the dilutive effects of subordinate securities. In the OPM, the exercise price is based on a comparison with the overall equity value rather than per-share value.
Allocation model inputs
The following presents the quantitative information about the significant unobservable inputs used in the fair value measurement of the Group's subsidiary preferred shares liability:
|
As of : |
|
30 June 2022 |
|
31 December 2021 |
|
Volatility |
|
75.0% |
|
77.7% |
|
Time to Liquidity (years) |
|
1.50 |
|
2.00 |
|
Risk-Free Rate |
|
2.86% |
|
0.73% |
The change in fair value of the subsidiary preferred shares is recorded in Finance cost from IFRS 9 fair value accounting in the consolidated statement of comprehensive loss.
Sensitivity Analysis
The following summarises the sensitivity from the assumptions made by the Company in respect to the unobservable inputs used in the fair value measurement of the Group's financial liabilities:
|
As of: |
|
30 June 2022 |
|
31 December 2021 |
|||
|
|
|
$'000 |
|
$'000 |
|||
|
Input |
Sensitivity range |
|
|
|
|||
|
Enterprise Value |
-2% |
(80) |
|
(3) |
|||
|
|
+2% |
35 |
|
35 |
|||
|
Volatility |
-10% |
(124) |
|
35 |
|||
|
|
+10% |
35 |
|
(3) |
|||
|
Time to Liquidity |
-6 months |
80 |
|
35 |
|||
|
|
+6 months |
195 |
|
(3) |
|||
|
Risk-Free Rate |
-0.09% / -0.17% |
80 |
|
35 |
|||
|
|
0.03%/ 0.12% |
195 |
|
(3) |
|||
The change in fair value of the subsidiary preferred shares is recorded in Finance cost, net in the consolidated statement of comprehensive loss.
The share-based payments for the period were $0.1 million (HY21: $0.2 million) comprising of charges related to the LTIP and the other subsidiary plans. The primary changes affecting the half year period were related to the following:
Under the UK Long Term Incentive Plan ("LTIP"), awards of Ordinary Shares may be made to employees, officers and directors, and other individuals providing services to the Company and its subsidiaries. Awards may be granted in the form of share options, share appreciation rights, restricted or unrestricted share awards, performance share awards, restricted share units, phantom-share awards and other share-based awards. Vesting is subject to the achievement of certain performance conditions and continued services of the participant.
Awards have been granted under the LTIP based on the following vesting criteria:
• awards subject to performance conditions based on the Company's total shareholder return ("TSR") performance or relative total shareholder return (rTSR) performance over a defined of time;
• awards subject to performance conditions based on a basket of shareholder value metrics ("SVM"). Performance is assessed on these measures on a scorecard basis over a defined period of time;
• awards that vest 100 per cent after a period of time subject to continued service condition only.
On 10 June 2019, the Board determined to retire the long term incentive plan (LTIP) scheme and therefore no future awards will be made to executive directors, management and other employees. Historic awards remained outstanding and eligible to vest in accordance with their terms. A significant majority of the outstanding awards are subject to relative total shareholder return (TSR) performance; however, at the current share price, the performance criteria of these awards will not be met and therefore, no shares are expected to be issued under such awards.
No shares were issued in respect of historic awards under the LTIP and no stock option activity was noted during the six months ended 30 June 2022 (HY21 nil).
The share grants that vest upon the occurrence of a market condition (i.e. the TSR performance) and service condition were adjusted to current market price at the date of the grant to reflect the effect of the market condition on the non-vested shares' value. The Company used a Monte Carlo simulation analysis utilising a Geometric Brownian Motion process with 50,000 simulations to value those shares. The model takes into account share price volatilities, risk-free rate and other covariance of comparable UK public companies and other market data to predict distribution of relative share performance. This is applied to the reward criteria to arrive at expected value of the TSR awards.
The share grants that vest only upon the occurrence of a non-market performance condition (i.e. the SVM grants) and service condition or upon passage of time were valued at the fair value of the shares on the date of the grants. The number of instruments included in the measurement of the transaction amount is subsequently adjusted so that, ultimately, the amount of recognised share-based expense is based on the number of instruments that eventually vest. None of the outstanding awards under the LTIP as of 30 June 2022 are subject to SVM vesting.
The accounting charge does not necessarily represent the intended value of share-based payments made to recipients, which are determined by the Remuneration Committee according to established criteria. The share-based payment charge for the period related to the UK LTIP was $17.4 thousand (HY21: $0.2 million).
During the six-month period ended 30 June 2022, no units have vested under the LTIP and respectively no equivalent number of common stock shares were issued to current and former employees and directors of the Group in exchange for a settlement price of £0.01 per share.
The US Stock Option/Stock Issuance Plan (the "US Stock Plan") was originally adopted by Allied Minds, Inc. (now Allied Minds, LLC) in 2008. The US Stock Plan provides for the grant of share option awards, restricted share awards, and other awards to acquire common stock of Allied Minds, Inc. (now Allied Minds, LLC). All stock options granted to employees under this plan are equity settled, for a ten-year term. Pursuant to the Company's IPO in 2014, Allied Minds plc adopted and assumed the rights and obligations of Allied Minds, Inc. under this plan except that the obligation to issue Common Stock is replaced with an obligation to issue ordinary shares to satisfy awards granted under the US Stock Plan. As of 19 June 2014, the maximum number of options reserved under the plan were issued and outstanding and as a result of the Company's IPO in 2014, all issued and outstanding options vested on 19 June 2014. The Company does not intend to make any further grants under the US Stock Plan.
No new stock option grants were awarded in the half-year 2022 and 2021 under the Allied Minds 2008 Plan.
11. Financial Instruments and Related Disclosures
|
As of 30 June 2022 (Unaudited): |
|
|
|
|
||||||||||
|
|
|
|
|
|
$'000 |
|
||||||||
|
|
|
|
|
Carrying |
|
Fair value |
|
|
||||||
|
|
|
|
|
Amount |
|
Level 1 |
|
Level 2 |
|
Level 3 |
|
Total |
|
|
|
Financial assets designated as fair value through profit or loss |
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
Investments at fair value |
|
33,990 |
|
― |
|
― |
|
33,990 |
|
33,990 |
|
|
|
|
Loans and receivables |
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
Cash and cash equivalents |
|
10,208 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Trade and other receivables |
|
6,488 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Security and other deposits |
|
641 |
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
51,327 |
|
― |
|
― |
|
33,990 |
|
33,990 |
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financial liabilities designated as fair value through profit or loss |
|
|
|
|
|
|
|
|
|
|
|
|
||
|
Subsidiary preferred shares |
|
951 |
|
― |
|
― |
|
951 |
|
951 |
|
|
||
|
|
Convertible notes |
|
6,824 |
|
― |
|
― |
|
6,824 |
|
6,824 |
|
|
|
|
Financial liabilities measured at amortised cost |
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
Trade and other payables |
|
1,443 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Lease liability |
|
391 |
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
|
9,609 |
|
― |
|
― |
|
7,775 |
|
7,775 |
|
|
|
|
As of 31 December 2021 (Audited): |
|
|
|
|
||||||||||
|
|
|
|
|
|
$'000 |
|
||||||||
|
|
|
|
|
Carrying |
|
Fair value |
|
|
||||||
|
|
|
|
|
Amount |
|
Level 1 |
|
Level 2 |
|
Level 3 |
|
Total |
|
|
|
Financial assets designated as fair value through profit or loss |
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
Investments at fair value |
|
33,984 |
|
- |
|
- |
|
33,984 |
|
33,984 |
|
|
|
|
|
Convertible note receivable |
|
4,500 |
|
- |
|
- |
|
4,500 |
|
4,500 |
|
|
|
|
Loans and receivables |
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
Cash and cash equivalents |
|
9,710 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Trade and other receivables |
|
5,912 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Security and other deposits |
|
594 |
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
54,700 |
|
- |
|
- |
|
38,484 |
|
38,484 |
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financial liabilities designated as fair value through profit or loss |
|
|
|
|
|
|
|
|
|
|
|
|
||
|
Convertible notes |
|
3,109 |
|
- |
|
- |
|
3,109 |
|
3,109 |
|
|
||
|
|
Subsidiary preferred shares |
|
1,255 |
|
- |
|
- |
|
1,255 |
|
1,255 |
|
|
|
|
Financial liabilities measured at amortised cost |
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
Trade and other payables |
|
1,061 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Lease liability |
|
873 |
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
|
6,298 |
|
- |
|
- |
|
4,364 |
|
4,364 |
|
|
|
The fair value of financial instruments that are not traded is determined by using valuation techniques that maximise the use of observable market data where it is available and rely as little as possible on entity specific estimates. If all significant inputs required to fair value an instrument are observable, the instrument is included in Level 2. Where the inputs for determining the fair value of financial instruments are not based on observable market data, the instrument is included in Level 3.
Cash and cash equivalents, trade receivables, and trade payables are carried at cost, which approximates fair value because of their short-term nature.
For assumptions used in the fair value measurement of the Group's convertible notes designated as Level 3.
|
For the six months ended: |
Unaudited 30 June 2022 |
|
Unaudited 30 June 2021 |
|
|
$'000 |
|
$'000 |
|
|
|
|
|
|
Short-term employee benefits |
151 |
|
837 |
|
Share-based payments |
- |
|
- |
|
Total |
151 |
|
837 |
Compensation of the Group's key management personnel includes salaries, health care and other non-cash benefits. Share-based payments are subject to vesting terms over future periods.
|
For the six months ended: |
30 June 2022 |
|
30 June 2021 |
|
|
$'000 |
|
$'000 |
|
|
|
|
|
|
Non-executive Directors' fees |
151 |
|
173 |
|
Non-executive Directors' share-based payments |
- |
|
- |
|
Total |
151 |
|
173 |
Executive management and Directors of the Company control 0.6 % (HY21: 0.6 %) of the voting shares of the Company as of 30 June 2022.
13. Taxation
The Company has evaluated subsequent events through 29 September 2022, which is the date the Condensed Consolidated Interim Financial Statements are available to be issued.
On 23 August 2022, the remaining TouchBistro shares were released from the escrow account and as a result, Allied Minds received $0.4 million in proceeds from the pre-arranged sale of these shares. There were no claims against the escrowed shares by TouchBistro and this now fully liquidates Allied Minds' investment in Touch Bistro.
On 9 September 2022, in order to ensure BridgeComm can bid for US Space Development Agency business as a prime contractor, Allied Minds agreed to a new ownership structure with Aeroequity Industrial Partners ("AEI"). Post the period end, in order to implement this structure, $2.0 million of existing Allied Minds debt with BridgeComm was not converted. Allied Minds' fully diluted ownership prior to the transaction was 62.92%.
Also on 9 September 2022, BridgeComm closed a $2.0 million Series B-2 financing in which both AEI and Allied Minds invested $1 million each (inclusive of previous bridge loans), in order for the company to continue operations whilst it seeks to raise further funds from interested investors. This reduced Allied Minds' issued and outstanding ownership to 41.49% (39.77% fully diluted). As a result of this change in ownership holding Allied Minds no longer controls BridgeComm and at the date of the transaction it has been deconsolidated from the Group. Going forward Allied Minds has significant influence and will equity account for the investment held under IAS 28.
The Directors confirm to the best of their knowledge that:
a) the Condensed Consolidated Interim Financial Statements have been prepared in accordance with UK adopted International Accounting Standard 34, ''Interim Financial Reporting''and give a true and fair view of the assets, liabilities, financial position and profit or loss of the Group as required by the FCA's Disclosure Guidance and Transparency Rules (4.2.4R); and
b) the Interim Management Report includes a fair review of the information required by the FCA's Disclosure Guidance and Transparency Rules (4.2.7R and 4.2.8R).
The Directors of Allied Minds plc and their functions are listed below.
By order of the Board
Bruce Failing,
Non-Executive Chairman
30 September 2022
08998697
Beaufort House
51 New North Road
Exeter EX4 4EP
United Kingdom
Sam Dobbyn (Independent Non-Executive Director)
Casey McDonald (Independent Non-Executive Director)
INDEPENDENT REVIEW REPORT TO ALLIED MINDS PLC
Conclusion
Based on our review, nothing has come to our attention that causes us to believe that the condensed set of financial statements in the half-yearly financial report for the six months ended 30 June 2022 is not prepared, in all material respects, in accordance with UK adopted International Accounting Standard 34 and the Disclosure Guidance and Transparency Rules of the United Kingdom's Financial Conduct Authority.
We have been engaged by the company to review the condensed set of financial statements in the half-yearly financial report for the six months ended 30 June 2022 which comprises the Condensed Consolidated Statement of Comprehensive Income, Condensed Consolidated Statement of Financial Position, Condensed Consolidated Statement of Changes in Equity and Condensed Consolidated Statement of Cash Flows; and associated notes.
Basis for conclusion
We conducted our review in accordance with International Standard on Review Engagements (UK) 2410, "Review of Interim Financial Information Performed by the Independent Auditor of the Entity" ("ISRE (UK) 2410"). A review of interim financial information consists of making enquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing (UK) and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.
As disclosed in note 1, the annual financial statements of Allied Minds plc (the 'company') and its subsidiaries (the 'Group') are prepared in accordance with UK adopted international accounting standards. The condensed set of financial statements included in this half-yearly financial report has been prepared in accordance with UK adopted International Accounting Standard 34, "Interim Financial Reporting.
Conclusions relating to going concern
Based on our review procedures, which are less extensive than those performed in an audit as described in the Basis for conclusion section of this report, nothing has come to our attention to suggest that the directors have inappropriately adopted the going concern basis of accounting or that the directors have identified material uncertainties relating to going concern that are not appropriately disclosed.
This conclusion is based on the review procedures performed in accordance with ISRE (UK) 2410, however future events or conditions may cause the [group/company] to cease to continue as a going concern.
Responsibilities of directors
The directors are responsible for preparing the half-yearly financial report in accordance with the Disclosure Guidance and Transparency Rules of the United Kingdom's Financial Conduct Authority and prepared in a form consistent with that which will be adopted in the Group's annual accounts having regard to the accounting standards applicable to such annual accounts.
In preparing the half-yearly financial report, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.
Auditor's responsibilities for the review of the financial information
In reviewing the half-yearly report, we are responsible for expressing to the Company a conclusion on the condensed set of financial statement in the half-yearly financial report. Our conclusion, including our Conclusions Relating to Going Concern, are based on procedures that are less extensive than audit procedures, as described in the Basis for Conclusion paragraph of this report.
Use of our report
Our report has been prepared in accordance with the terms of our engagement to assist the Company in meeting the requirements of the Disclosure Guidance and Transparency Rules of the United Kingdom's Financial Conduct Authority and for no other purpose. No person is entitled to rely on this report unless such a person is a person entitled to rely upon this report by virtue of and for the purpose of our terms of engagement or has been expressly authorised to do so by our prior written consent. Save as above, we do not accept responsibility for this report to any other person or for any other purpose and we hereby expressly disclaim any and all such liability.
BDO LLP
Chartered Accountants
London, UK
Date: 29 September 2022
BDO LLP is a limited liability partnership registered in England and Wales (with registered number OC305127).